| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.4 |